Eosinophils are terminally differentiated, bone marrowderived, granule-containing leukocytes, as are neutrophils, basophils and mast cells. These granule-containing cells can be categorized based on common precursors; eosinophils, basophils and mast cells develop from a GATA1 + granulocyte-monocyte precursor (GMP) that is distinct from the GATA1 − GMP that gives rise to neutro phils, and monocytes and macrophages 1 . Moreover, the granule populations and their contents differ substantially between cell types. Human eosinophils contain a single population of granules that has long been known to be rich in four cationic proteins: major basic protein 1 (MBP1; also known as MBP and PRG2), eosinophil cationic protein (ECP; also known as RNase3), eosinophil-derived neurotoxin (EDN; also known as RNase2) and eosinophil peroxidase (EPX; also known as EPO). The properties and biological activities of these cationic proteins (reviewed in REF. 2) have been a focus for studying the roles of eosinophils as effector cells in host defence and, in particular, in mediating inflammatory responses in human diseases. Mouse eosinophils contain orthologues of MBP1 and EPX, but ECP and EDN are absent (although other granule proteins with RNase activities are present) 3 . On the basis of their cationic proteins, eosinophils were first identified more than a century ago by staining with acidic dyes, such as eosin. Subsequently, transmission electron microscopy has revealed an additional signature feature of eosinophils in that eosinophil granules, uniquely among the granule-containing leukocytes, contain a crystalline core.
Eosinophils are terminally differentiated, bone marrowderived, granule-containing leukocytes, as are neutrophils, basophils and mast cells. These granule-containing cells can be categorized based on common precursors; eosinophils, basophils and mast cells develop from a GATA1 + granulocyte-monocyte precursor (GMP) that is distinct from the GATA1 − GMP that gives rise to neutro phils, and monocytes and macrophages 1 . Moreover, the granule populations and their contents differ substantially between cell types. Human eosinophils contain a single population of granules that has long been known to be rich in four cationic proteins: major basic protein 1 (MBP1; also known as MBP and PRG2), eosinophil cationic protein (ECP; also known as RNase3), eosinophil-derived neurotoxin (EDN; also known as RNase2) and eosinophil peroxidase (EPX; also known as EPO). The properties and biological activities of these cationic proteins (reviewed in REF. 2) have been a focus for studying the roles of eosinophils as effector cells in host defence and, in particular, in mediating inflammatory responses in human diseases. Mouse eosinophils contain orthologues of MBP1 and EPX, but ECP and EDN are absent (although other granule proteins with RNase activities are present) 3 . On the basis of their cationic proteins, eosinophils were first identified more than a century ago by staining with acidic dyes, such as eosin. Subsequently, transmission electron microscopy has revealed an additional signature feature of eosinophils in that eosinophil granules, uniquely among the granule-containing leukocytes, contain a crystalline core.
Eosinophils are cells of the innate immune system that are found in evolutionary history from early vertebrates onwards 3 . Based on cytochemical staining, eosino phils can be readily counted in the blood, where they are a minor (<5%) component of circulating leukocytes; larger numbers of tissue-dwelling eosinophils are present outside of the vasculature. The number of eosino phils in the blood and some tissues is known to increase during specific immune responses, including host responses to helminth parasite infections, and in allergic diseases, including forms of asthma 4 . This eosino philia is associated with T helper 2 (T H 2) cellmediated immune responses, including the production of IL-5, which enhances eosinophilopoiesis and eosinophil activation. Therefore, based on their ability to de granulate and release their cationic granule proteins (which have been shown to kill helminths in vitro), eosinophils were postulated to have evolved to exert hostprotective, helminthotoxic functions. However, multiple studies, including those in eosinophil-deficient or eosinophil-enriched (Il5-transgenic) mice, have shown more nuanced roles for eosinophils 5, 6 . In many experimental models of helminth infection, eosinophils were not shown to have any protective effects.
Side scatter (SSC) parameter
In flow cytometry, the SSC parameter is a measurement of light scatter taken at a ninety-degree angle relative to the laser. As cellular components such as granules increase the light refraction, SSC is a useful parameter to distinguish cell populations on the basis of their cellular complexity.
Multicellular helminth parasites, having co-evolved with their hosts, may even benefit from the presence of eosinophils; for example, in the case of muscle-encysting Trichinella larvae, eosinophil-derived cytokines (including IL-10 and IL-4) suppress host responses that are otherwise toxic to the larvae 4, 7 . Thus, the views that eosinophilmediated immune responses to parasites are beneficial to the host and that eosinophil-associated allergic diseases are an unwanted side effect have been challenged.
It is now clear that eosinophils, which are mainly tissue-dwelling leukocytes, have a broader tissue distribution than previously appreciated and are more than just terminally differentiated effector cells. Rather, as cells of the innate immune system, eosinophils are sources of a wide variety of cytokines, and their functions include more than exocytotic degranulation. As such, eosinophils are increasingly recognized to participate in both immune homeostasis and immunity (FIG. 1) . In this Review, we consider the evolving knowledge of eosinophils from mice and humans that is relevant to the functions of eosinophils as distinct sources of cytokines in varied tissue sites that are not involved in host defence against parasites or allergic disease. We consider the limitations of and improvements in detecting eosinophils in tissue sites; the composition of eosinophils, including their preformed stores of cytokines; the increasing understanding of the ultrastructural and molecular mechanisms that control selective secretion from human eosinophils; the cellular sources of eosinophil-activating IL-5; and the wide-ranging roles that eosinophils have in homeostatic and immunological processes in addition to and distinct from their terminal effector functions.
Detecting tissue-resident eosinophils
In contrast to the increased numbers of recruited eosinophils in associated diseases, recognizing the normal presence of eosinophils within tissue sites has been more difficult. Complementary experimental approaches are now able to detect and evaluate eosinophils present in tissue sites more sensitively.
In situ tissue analyses
Conventional detection of eosinophils in tissues based on light microscopy is limited by the use of 5-10 μm thick tissue sections, which enable only partial sampling of the tissue, and the indistinct histological resolution of common stains, which often do not detect all tissue-resident eosinophils. Moreover, as shown in various allergic and other eosinophil-enriched diseases, some tissues may lack detectable intact eosinophils because these cells have already undergone cytolysis or de granulation; the prior presence of these cells is evidenced by extracellular eosinophil granules and/or granule-derived proteins, such as MBP1. Although electron microscopy is limited to an even greater extent by the small fields that are amenable to visualization, this technique has been used to detect extracellular, core-containing granules in tissues that could not be detected by conventional histological staining 8 , which has provided strong evidence of an association between eosinophil cell-free granules and disease pathology. Moreover, the generation of monoclonal antibodies raised against eosinophil granule proteins (such as MBP1 and EPX) has greatly enhanced the sensitivity of detecting tissue eosinophils by immuno histochemistry and immunofluorescence. However, whereas immunofluorescence staining of eosinophil granule proteins has markedly improved the detection of eosinophils, the presence of low-abundance eosinophils in most normal tissues was not appreciated historically. For example, in a study using anti-MBP1 immuno fluorescence staining, eosinophil infiltration was not detectable in human tissues, except in the lymph nodes, spleen, thymus and small intestine 9 .
Digesting tissues to isolate eosinophils
Newer, complementary approaches that robustly investigate low-abundance tissue eosinophils use methods for tissue digestion to release resident cells as single-cell suspensions that are amenable to flow cytometric analyses. A recent flow cytometry study of immune cells isolated from normal non-lymphoid tissues in mice showed that eosinophils are indeed normally present in many organs 10 . Eosinophils constituted 5% of the total myeloid cells in the lungs, 1% in the heart, liver and kidneys, and 6% in the skin 10 . Thus, eosinophils are now being assayed in tissue sites where they were not previously well documented.
Comprehensive analyses of tissue eosinophils by flow cytometry rely on the identification of surface markers and the high granularity of eosinophils, which is revealed by the side scatter (SSC) parameter
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. Surface expression of IL-5 receptor subunit α (IL-5Rα), CC-chemokine receptor 3 (CCR3) or sialic acid-binding immunoglobulinlike lectin 8 (Siglec-8) (in humans) or Siglec-F (also known as Siglec-5) (in mice) in the absence of other lineage-specific markers and/or in combination with an SSC hi gating strategy can be used to identify eosinophils. (However, it should be noted that CCR3 is not expressed by immature eosinophils from fetal liver 12 .) Importantly, the choice of an appropriate eosinophil gating strategy depends upon the particular tissue and disease state that is being analysed, as certain markers that are often used to identify non-eosinophils (such as CD11C, GR1, F4/80 and MHC class II molecules) are expressed by eosinophils recruited into some tissue sites [13] [14] [15] [16] [17] [18] [19] 
Eosinophil granule contents
Crystalline core-containing granules are central to the formation and functions of eosinophils. As indicated by three experimental approaches, impaired granule biogenesis during eosinophilopoiesis is lethal for developing eosinophils [21] [22] [23] . In the first study, combined ablation of the two main granule-derived Eosinophils are a source of lipid mediators, granule-derived cationic proteins and a large number of chemokines and cytokines (many of which are stored preformed within eosinophil intracellular granules) that have wide-ranging effects in health and disease. APRIL, a proliferation-inducing ligand; CCL, CC-chemokine ligand; CXCL, CXC-chemokine ligand; DC, dendritic cell; ECP, eosinophil cationic protein; EDN, eosinophil-derived neurotoxin; EPX, eosinophil peroxidase; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFNγ, interferon-γ; MBP1, major basic protein 1; MMP9, matrix metalloproteinase 9; NGF, nerve growth factor; PDGF, platelet-derived growth factor; SCF, stem cell factor; TGF, transforming growth factor; T H , T helper; TIMP1, tissue inhibitor of metalloproteinases 1; TNF, tumour necrosis factor; VEGF, vascular endothelial cell growth factor.
cationic proteins (EPX and MBP1) resulted in the selective loss of eosinophil lineage-committed progenitors 23 . Subsequent studies showed that inhibition of the cysteine protease inhibitor cystatin F 22 or of the stress-response transcription factor X-box-binding protein 1 (XBP1) 21 markedly decreased or completely abolished, respectively, eosinophil differentiation.
Taken together, these studies suggest that the generation and safe packaging of cationic granule proteins into intracellular granules are essential for eosinophil development and subsequent survival. The granules of mature eosinophils, as best studied for human eosinophils, contain -in addition to their cationic proteins -preformed stores of many cytokines, chemokines and growth factors (collectively referred to here as cytokines). That cytokines are stored as preformed proteins within human eosinophil granules was first indicated by the microscopic immunolocalization of cytokines, including tumour necrosis factor (TNF), IL-4, IL-6 and IL-13, to granules [24] [25] [26] . In a quantitative assessment, eosinophils from six human donors all contained preformed interferon-γ (IFNγ), IL-4, IL-6, TNF, IL-10, IL-12 (p70) and IL-13, each of which was predominantly present as preformed protein within eosinophil granules 24 . Thus, at least for human eosinophils, eosinophil-derived cytokines that are preformed proteins and do not require de novo transcription are stored within eosinophil granules. Human eosinophils can also generate cytokines based on transcriptional activation and de novo protein synthesis 27 , and they further regulate cytokine protein expression through the stabilization of mRNA transcripts 28 . Deciphering the relative contributions of de novo transcription, mRNA stabilization and mobilization of cytokines from preformed granule stores remains an important unanswered question in eosinophil biology
.
Mouse eosinophils are also a source of many cytokines 3 . For example, mouse eosinophils contain mRNA and protein for a proliferation-inducing ligand (APRIL; also known as TNFSF13), IL-4, IL-6, IL-10 and TNF 29 , as well as for a large number of chemokines 30 . Mouse eosinophils are a source of both type 1 cytokines 31 and type 2 cytokines. Mouse eosinophils acquire transcripts for IL-4 and IL-13 during differentiation 32 , but it is not yet clear to what extent mouse eosinophils contain preformed cytokine proteins and whether these cytokines are localized to eosinophil granules, as has been found for human eosinophils.
Modes of eosinophil secretion
Human eosinophil granules, in addition to their crystalline core and surrounding matrix, are now recognized to contain an intragranular membrano-vesicular network that is thought to be involved in the selective secretion of granule-stored proteins [33] [34] [35] [36] [37] . Preformed, granule-stored cytokines can be released by three main secretory processes: classical exocytosis, cytolysis with granule release and piecemeal degranulation (PMD), of which cytolysis and PMD are more relevant to eosinophils (FIG. 2) .
Classical exocytosis
Unlike the exocytotic degranulation of mast cells and basophils that is mediated by ligation of the IgE receptor FcεRI, a physiological mechanism to elicit comparable acute degranulation of eosinophils (that is, the release of entire granule contents) has rarely been observed in vivo, although eosinophils can be observed to de granulate on the surface of large multicellular helminths in vitro 38 . Rather, ultrastructural studies show that in vivo, the majority of tissue eosinophils release their granule-derived contents secondary to cytolysis, with extracellular expulsion of intact granules, or through vesicle-mediated PMD.
Cytolysis with granule release
Human eosinophils can undergo cytolysis in vivo 39 , which is characterized by chromatin de-condensation, dissolution of nuclear and plasma membranes, formation of extruded nuclear DNA nets and extra cellular expulsion of membrane-bound granules 40, 41 . Using electron microscopy, the presence of extracellular,
Box 1 | Experimental caveats regarding studies of eosinophils
Cytokine mRNA and protein assays. Eosinophils respond rapidly to external stimuli by the differential release of numerous cytokines and chemokines. Both human and mouse eosinophils undergo stimulus-induced cytokine gene transcription and also can contain stabilized cytokine mRNA transcripts 28 to enable de novo cytokine synthesis 32 . Moreover, eosinophils store preformed cytokines and chemokines within their intracellular granules, which are available for rapid stimulus-induced mobilization and release through piecemeal degranulation (PMD). For cytokine proteins that have already been synthesized and packaged within eosinophil granules, the levels of cytokine-specific mRNAs may reflect neither the intracellular content nor the levels of secreted cytokines 30 ; therefore, studying the eosinophil transcriptome may not be sufficient to monitor the levels of preformed cytokine proteins within eosinophils that are available for regulated secretion 145 . The relative contributions of newly synthesized cytokines or stabilized mRNA transcripts versus preformed cytokines that are readily releasable through PMD from granule stores have not been studied.
Detecting intracellular cytokines. Cell-permeabilization protocols are commonly used to study eosinophils, often following stimulation in the presence of brefeldin A to inhibit Golgi-derived secretion. From our studies, such eosinophil permeabilization strategies can enable the intracellular detection of cytokines, but this detection is mainly restricted to those cytokines in the secretory vesicular pool. Intracellular eosinophil granules are not permeabilized by these common protocols to enable detection of their preformed cytokine stores. Indeed, increased detergent concentrations fail to detect granule-contained cytokine proteins and -probably by dissolving the cytoplasmic vesicles that may contain cytokines -lead to a decrease in detectable levels of intracellular eosinophil cytokines. Of note, brefeldin A also functions within eosinophil granules to collapse the membrano-vesicular secretory apparatus 65 . Immunolocalization of cytokines to eosinophil granules and more quantitatively direct assays on eosinophil granules isolated by subcellular fractionation are needed to ascertain the cytokine content of eosinophils, including those stored in granules and being mobilized into cytoplasmic secretory vesicles.
Cytokine reporter mice. Although cytokine reporter mice can indicate which cells transcribe specific cytokines -for example, 4get mice identify cells that are capable of IL-4 synthesis -the local secretion of eosinophil-derived cytokine proteins needs to be determined, including in tissue sites. In 4get mice, the secretion of IL-4 protein from these cells requires a second activating process 97 .
In vitro derivation of eosinophils. Studies using primary eosinophils are hindered by the small numbers of eosinophils that can be recovered from accessible compartments such as blood and the short ex vivo lifespan of isolated eosinophils. Mature eosinophils are not transfectable, nor are they amenable to RNA interference methods. To overcome these technical challenges, studies have used eosinophil-like cell lines, and protocols have been developed to derive eosinophils from human and mouse bone marrow 146 . Although cell lines and bone marrow-derived eosinophils are of value in understanding eosinophil development, it remains to be determined whether these cells have fully matured eosinophil granules capable of differential secretion of granule-derived cytokines and other proteins.
Electron microscopy. Whereas early electron microscopy studies could be used to evaluate eosinophil granules, the cytoplasmic secretory vesicles of eosinophils were usually not preserved, and the precise subcellular localization of cytokines was difficult to determine using cytokine-specific antibodies conjugated to large gold particles. With refinements in fixation methods and improvements in immunonanogold localization at the ultrastructural level [64] [65] [66] , these features can now be better studied in mouse and human eosinophils. 
Type 1 cytokines
Cytokines typically produced by T helper 1 cells, including IL-2, interferon-γ and IL-12. well-defined, electron-dense crystalline core and an electron-lucent outer matrix, surrounded by a trilaminar membrane. B | Eosinophils adherent to the surface of a large multicellular parasite have been shown to undergo classic exocytotic degranulation, wherein intracellular granules fuse with the plasma membrane, creating a secretory pore through which the entire granule contents are released. In compound exocytosis, granule-granule fusions occur within the cytoplasm, forming secretory channels that enable the wholesale degranulation of the combined content of multiple granules. C | By contrast, piecemeal degranulation (PMD) differentially releases granule-derived proteins, including cytokines, as discrete packets. As shown in panel Ca, granules within cells undergoing PMD exhibit varying degrees of ultrastructural alteration, including an apparent reorganization of electron-dense contents and the appearance of a membranous network of tubules within granules. As shown in panel Cb, granule-derived proteins are differentially mobilized into small round vesicles and tubular structures, the latter termed eosinophil sombrero vesicles (EoSVs), that emerge from mobilized granules and seem to derive directly from the intragranular membrano-vesicular network of tubules. As shown for eotaxin-elicited PMD of IL-4 in panel Cc, tubular EoSVs express lumen-oriented receptor chains that are bound by their cognate cytokine ligand, which indicates that a mechanism of receptor-mediated chaperoning may contribute to differential cytokine secretion. After emerging from granules, cytoplasmic EoSVs and small vesicles traverse the cytoplasm and fuse with the plasma membrane to release their granule-derived cargo. D | Eosinophils may also be induced to undergo a cytolytic cell death pathway characterized by dissolution of the nuclear and plasma membranes, extrusion of DNA nets and expulsion of intact granules that are observed individually and as clusters of cell-free extracellular granules within tissues. A portion of cell-free, extracellularly deposited eosinophil granules retain an intact trilaminar outer membrane, express outwardly oriented functional receptors on their outer membranes as shown in the right panel, and remain competent to undergo stimulus-dependent secretion within tissues.
Type 2 cytokines

Intragranular membrano-vesicular network
Intricate network of interconnected vesicular tubules that is evident within eosinophil granules undergoing piecemeal degranulation. These tubules are thought to give rise to granule-derived secretory vesicles.
Eosinophilic oesophagitis
Chronic allergic inflammatory disease characterized by the accumulation of a large number of eosinophils in the oesophagus, an organ that is normally devoid of eosinophils.
Immunonanogold localization
Electron microscopy technique using antibodies conjugated to very small (1.4 nm) gold particles to enable subcellular localization of proteins.
Eosinophil sombrero vesicles
(EoSVs). C-Shaped tubular vesicles that are named in recognition of their similarity in cross-sectional appearance in electron micrographs to a Mexican hat.
membrane-bound granules with the signature crystalline core of eosinophils has been documented in numerous tissues and secretions, including in multiple diseases of the respiratory tract, such as asthma [42] [43] [44] [45] , allergic rhinitis [46] [47] [48] , nasal polyps 49 , eosinophilic pneumonia [50] [51] [52] and other eosinophil-associated disorders [53] [54] [55] [56] [57] [58] . For example, in human eosinophilic oesophagitis, cell-free eosinophil granules were present in 70% of the electron microscopy images of oesophageal tissue sections 59 . In mice, extracellular eosinophil granules have been detected in gastrointestinal tissues 60 but have not yet been examined more widely. Although the mechanisms mediating eosinophil cytolysis in vivo remain to be defined, the presence of cell-free, intact, membrane-bound eosinophil granules that retain their content of preformed cytokines and cationic proteins is well recognized in diverse human diseases [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] 61 . These extracellular eosinophil granules are thought to have functional roles, as they remain ligand-responsive, secretion-competent structures 8, 62 . Isolated human eosinophil granules express membrane receptors, including for a chemokine (CCR3), a cytokine (IFNγ receptor α-chain, also known as IFNGR1) and cysteinyl leukotrienes (CysLTR1, CysLTR2 and the purinergic receptor P2Y12); mouse eosinophil granules express CCR3, but not IFNγ receptor α-chain 60, 63 . These receptors are expressed on the external membrane surfaces of eosinophil granules and so are topologically oriented to engage their ligands in the extracellular environment 60,62,63 . Ligand engagement of these receptors can activate signal transduction pathways within granules, including kinase-mediated signalling (for example by p38 MAP kinase) 62 . Moreover, ligand-stimulated cellfree granules can differentially secrete their content of cationic proteins (ECP and EPX) and cytokine proteins 62 . For example, human eosinophil granules stimulated with IFNγ release IL-4 and IL-6, but not IL-8, IL-10, IL-12 (p70) or IL-13 (REF. 62 ). Thus, cytolytic cell death of eosinophils can provide a means whereby eosinophil granule-derived proteins may continue to be released selectively from granules into tissues in the absence of intact eosinophils.
Piecemeal degranulation
In PMD, granule-derived proteins are differentially packaged into secretory vesicles that traverse the cytoplasm and fuse with the plasma membrane to deliver specific proteins to the extracellular space while leaving intracellular granules intact and available for repetitive rounds of PMD. Improvements in techniques for electron microscopy fixation and immunonanogold localization at the ultrastructural level have enabled structural insights into the mechanisms by which granule constituents can be mobilized into the secretory apparatus [64] [65] [66] . Eosinophil granules contain an intricate membrano-vesicular network of tubules that are collapsible by treatment with the vesicular transport inhibitor brefeldin A, concurrent with the loss of cytoplasmic small vesicles and eosinophil sombrero vesicles (EoSVs) 65 , and that therefore are likely to contribute directly to the formation of cytoplasmic secretory vesicles (FIG. 3A) .
Using immuno-electron microscopy localization, granule-derived, MBP1-containing vesicles have been shown in close proximity to mobilized granules, trafficking throughout the cytoplasm and fusing with the plasma membrane 33, 35 (FIG. 3B,C) . Electron tomography has enabled a 3D view of intracellular granules undergoing PMD and has confirmed that small vesicles and tubular secretory vesicles emerge out of mobilized granules as apparent extensions of the intragranular vesicular network 34, 65 . EoSVs 36 are morphological hallmarks of enhanced PMD in human eosinophils, as exemplified in an electron microscopy study of biopsy tissue from individuals with eosinophilic oesophagitis 59 .
In mouse eosinophils, PMD has been inferred by decreased intracellular chemokine contents 30 and demonstrated by electron microscopy studies of activated mouse eosinophils that exhibited structural changes within granules consistent with content emptying 60 . However, mouse eosinophils do not seem to exhibit the morphologically distinct EoSVs that are notable in human eosinophils.
Despite the fact that granules in human eosinophils contain numerous and diverse preformed cytokines, different stimuli uniformly elicit distinct and selective patterns of secretion of nominal type 1, type 2 and regulatory cytokines 24, 27 . Thus, based on studies of human eosinophils, the secretion of granule-stored cytokines by PMD is rapid, stimulus-dependent and highly differential in terms of which cytokines are secreted. However, it remains unclear how extracellular stimuli induce eosinophil granule secretion and how specific cytokines are selected from a heterogeneous cytokine pool within granules for packaging into secretory vesicles 37 . We have documented robust expression within eosinophil granules of the receptors for several cytokines that are stored preformed within granules 67 . The best studied of these is IL-4 receptor subunit α (IL-4Rα), which is more densely expressed within eosinophil granules than on the cell surface 33, 67 . When eosinophils were stimulated with eotaxin 1 (also known as CCL11) to secrete IL-4, there was a rapid increase in the level of intracellular vesicle-associated IL-4Rα accompanied by the translocation of IL-4 from granule stores into cytoplasmic secretory vesicles 67 . Immuno-electron microscopy showed that IL-4 within secretory vesicles was proximate to the vesicle membrane (FIG. 3D,E) . Furthermore, an IL-4Rα-binding antibody that competitively targets the IL-4-binding site on the receptor chain failed to detect the vesicle-associated IL-4Rα, which indicates that IL-4 is transported bound to its cognate receptor chain within secretory vesicles 67 . Of note, owing to the high surface membrane area to volume ratio of EoSVs that is in herent in their curved, elongated tubular structure, they are particularly well suited to a membrane receptor-mediated mechanism of cytokine transport. Taken together, these data indicate a potential role for cytokine receptors in the sorting and transport of granule-stored cytokines. 
Regulating tissue eosinophils
4get mice
Bicistronic IL-4 reporter mice were generated by the targeted addition of an internal ribosomal entry site-enhanced green fluorescent protein (IRES-eGFP) to generate IL-4-GFP-enhanced transcript (4get) mice.
Alternatively activated M2 macrophages
Anti-inflammatory cells that function in tissue repair and remodelling. M2 macrophages are characterized by the production of IL-10 and transforming growth factor-β.
(ILC2s), which are major IL-5-expressing cells within tissues 69, 74 . ILC2-derived IL-5 is implicated in the homeostatic homing of eosinophils into the small intestine 69 , eosinophil-dependent metabolic homeostasis in tissues 75 and fostering an eosinophil-rich inflammatory exudate into the lungs during an allergic response 76 (including in humans 77, 78 ). The epithelial cell-derived alarmins, IL-25, IL-33 and thymic stromal lymphopoietin, promote eosinophilia in part by eliciting IL-5 production by ILC2s 79, 80 . Although they are less specific than IL-5 for eosinophils, the cytokines IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) are also implicated in the priming, activation and survival of tissue eosino phils. Similarly to the receptor for IL-5, receptors for IL-3 and GM-CSF use the common β-chain, and their respective signalling pathways elicit both overlapping and distinct downstream effects in vivo (reviewed in REF. 81 ). GM-CSF is constitutively secreted by intestinal epithelial cells 82 and probably maintains intestinal eosino phils in a unique activation state 83 , such that it may be particularly important to the homeostatic functions of intestinal tissue eosinophils. In vivo, the tissue accumulation of eosinophils is ultimately determined by a complex balance between signalling induced by pro-survival factors such as IL-3, IL-5 and GM-CSF and signalling through eosinophil surfaceexpressed inhibitory receptors (reviewed in REF. 84 ), such as Siglec-8 (REF. 85 ), paired immunoglobulinlike receptor B (PIRB) 86 , leukocyte immunoglobulin-like receptor 3 (LIR3) 87 and IRp60 (also known as CD300A) 88 . Moreover, the manner whereby eosinophils die within tissues (apoptosis versus cytolysis) has important downstream implications for the tissue microenvironment, as cell-free granules released from cytolytic eosinophils can remain secretion-competent within tissues (see earlier). Delineating the tissue expression patterns of IL-3, IL-5 and GM-CSF and determining their differential effects on eosinophil activities in vitro and in vivo are active areas of research. It will also be important to determine the outcomes of combinatorial signalling downstream of the common β-chain and individual inhibitory receptors, which will have potential implications for the development of combinatorial therapies for the treatment of eosinophilic diseases.
Steady-state functions of tissue eosinophils
Elucidating the functions of eosinophils in tissues has been advanced by generating mouse strains that transgenically overexpress IL-5 and by developing mice deficient in eosinophils (reviewed in REF. 89 ). The latter include ΔdblGATA mice, in which deletion of a high-affinity GATA-binding site in the promoter region of the transcription factor Gata1 ablates the eosinophil lineage 90 ; PHIL mice, in which diphtheria toxin is expressed under the control of the eosinophil-specific Epx promoter 91 ; inducible eosinophil-deficient (iPHIL) mice, in which the human diphtheria toxin receptor has been inserted into the Epx genomic locus, enabling the temporal depletion of eosinophils by addition of exo genous diphtheria toxin 92 ; and eosinophil-targeting Cre recombinase-expressing (EoCre) mice, which enable targeted deletion of specific genes in eosinophils 93 . In parallel, the central role of eosinophil-derived cytokines in promoting eosinophil functions, particularly in tissue sites, has been supported by the generation of cytokine reporter mice that can sensitively detect cells transcribing specific cytokines in vivo 94 . Of note, IL-4, which is a canonical cytokine marker of T H 2 cellmediated immunity, has been studied in 4get mice 95 in response to helminth infection, showing that eosinophils -and, to a lesser extent, basophils and T H 2 cells -are sources of transcribed Il4 (REF. 96 ). Moreover, as discussed below, 4get mice have been particularly revealing of the roles of tissue-resident eosinophils as distinct sources of IL-4. These mice can be used to identify cells that have transcribed Il4, but the release of IL-4 protein from these cells is likely to require a second activating process 97 that has not been defined for mouse eosinophils in vivo.
Collectively, these approaches indicate that, in addition to their involvement in allergic inflammatory diseases and helminth parasite infections, eosinophils residing within specific tissue niches function to maintain tissue, metabolic and immune homeostasis in the steady state.
Steady-state development
Mammary gland and uterine eosinophils. Puberty hormones and growth factors initiate early development within the mammary glands of females, characterized by bifurcation, elongation and branching of the pre natal rudimentary ductal tree. Branching of the maturing ductal tree is shaped by soluble mediators and cellcell interactions provided by the surrounding stroma, which positively or negatively regulate the growth and shape of proliferating ducts. Alternatively activated M2 macrophages and eosinophils are prominent cellular constituents of the mammary gland stroma and are implicated in regulating elongation and branching, respectively, of the ductal tree 98, 99 . The influx of eosinophils into the mammary gland depends on the local production of eotaxins 100, 101 , and eotaxin 1-deficient mice (which have decreased numbers of mammary gland eosinophils) exhibit defective ductal branching 99 . Eosinophils are also recruited to the mammary glands during pregnancy, when further development occurs. Although the mechanism(s) by which eosinophils regulate ductal branching remain undefined, eosinophilderived transforming growth factor-β (TGFβ) and CC-chemokine ligand 6 (CCL6) have been implicated in the negative regulation of ductal branching and in promoting macrophage recruitment, respectively 99, 102 . Eosinophil recruitment to the healthy cycling uterus is well described, particularly in rodents. Eosinophils are the most prevalent type of innate immune cell within the uterus throughout the murine oestrous cycle, with numbers reaching a maximum at oestrus and meto estrus 11 . Eosinophil infiltration of the uterus is induced by oestradiol-driven local expression of eotaxin 1 (REF. 101 ). Similarly, eotaxin 1 and its receptor are detected within the endometrium throughout the human menstrual cycle 103 . Studies in humans and
Classically activated M1 macrophages
Macrophages that are activated by lipopolysaccharide and interferon-γ to secrete high levels of IL-12 and produce nitric oxide, promoting a pro-inflammatory antimicrobial response.
Mitochondrial brown fat uncoupling protein 1
Also known as thermogenin. This protein spans the inner mitochondrial membrane and functions as a proton transporter, thereby uncoupling the proton gradient that is produced during oxidative phosphorylation from ATP production, causing the chemical energy to instead be dissipated as heat.
Beige adipocytes
Adipocytes that express uncoupling protein 1 and have thermogenic capacity. They are induced in white adipose tissue by cold either directly or indirectly through activation of the β-adrenergic signalling pathway.
rodents have shown that eosinophils accumulate and degranulate in the uterus in association with the tissue-degradative processes that prepare the cervix for delivery 104 and during tissue-regenerative phases postpartum 105 . However, despite the cyclical appearance of uterine eosinophils and their apparent association with tissue degradation and subsequent uterine repair and remodelling processes, mice deficient in IL-5 or eotaxin 1, or genetically devoid of eosinophils, exhibit near normal pregnancy and parturition 101, 106 . Thus, specific, non-redundant roles for uterine eosinophils remain unclear.
Intestinal eosinophils. Eosinophils constitutively home to all regions of the gastrointestinal tract (with the exception of the oesophagus) [107] [108] [109] , driven by an eotaxin 1 gradient that is probably formed downstream of the actions of ILC2-derived cytokines on epithelial cells 69 . Intestinal eosinophils participate in mucosal immune homeostasis. For example, the absence of eosinophils is associated with decreased production of secretory IgA at the intestinal mucosa, alterations in the intestinal microbiome and dysregulated mucosal barrier integrity 110, 111 . Moreover, eosinophil-deficient mice exhibit alterations in the gut-associated lymphoid tissue -specifically, Peyer's patches are smaller and contain fewer cells, and decreased numbers of CD103 + T cells and DCs are present in the lamina propria 110 . Specific mechanisms of eosinophildependent effects on intestinal immune homeostasis have yet to be delineated, although eosinophil-derived TGFβ 110 and IL-1β 111 have been hypothesized to be involved in supporting the production of IgA.
Tissue regeneration
Eosinophils in regenerating muscle. Eosinophils are also associated with IL-4-driven regenerative responses to tissue injury 112, 113 . Efficient tissue regeneration in response to muscle injury probably involves the activation and proliferation of fibrocyte-adipocyte progenitors (FAPs) to promote a stromal environment that is favourable to myogenic differentiation 114 . FAPs have the dual potential to promote the differentiation of myogenic progenitors 114 or to themselves undergo adipogenesis 115 . The pivotal decision of FAPs to provide signals that enhance myogenic differentiation during muscle repair is driven by IL-4-and/or IL-13-induced signalling through FAPexpressed IL-4Rα. IL-4Rα-dependent functions of FAPs are required for both regenerating muscle fibres and the phagocytic removal of necrotic fibres. In a model of cardiotoxin-elicited muscle injury, 4get mice were used to show that eosinophils are the main IL-4-expressing cells that infiltrate injured skeletal muscle, and the regenerative response was severely compromised in ΔdblGATA (eosinophil-deficient) mice 113 .
Eosinophils in regenerating liver. Similarly, liver regeneration requires IL-4Rα expression by hepatocytes, and exogenous IL-4 is sufficient to promote hepatocyte proliferation in the absence of injury, which indicates that direct IL-4-induced signalling of hepatocytes drives liver regeneration 112 . Liver injury in mice causes an increase in the local production of eotaxin 1, and similar to injured skeletal muscles, recruited eosinophils are the main IL-4-expressing cells within injured livers. Eosinophil-deficient mice have an impaired regenerative response to partial hepatectomy or carbon tetrachlorideinduced liver injury, which directly implicates recruited eosinophils in liver regeneration 112 . These observations provide evidence that eosinophils and the IL-4 they produce contribute to tissue repair in two highly regenerative organs (skeletal muscle and liver). In each case, eosinophil-derived IL-4 mediates its effects on resident or recruited non-immune cells.
Metabolic homeostasis
Adipose tissue eosinophils. In lean mice, the majority of macrophages within visceral adipose tissue (VAT) are of the alternatively activated M2 phenotype; these cells express anti-inflammatory genes such as Il10 and arginase 1 (Arg1) and secrete products that support the insulin sensitivity of adipocytes 116 . By contrast, monocytes recruited into the VAT of obese mice predominantly develop characteristics of classically activated M1 macrophages and secrete pro-inflammatory cytokines, including TNF, that promote low-grade inflammation, leading to insulin resistance 116, 117 . The type 2 cytokines IL-4 and IL-13 drive macrophages towards an M2-like phenotype. Maintaining an anti-inflammatory milieu (and by extension glucose homeostasis) within adipose tissue thus requires a continual supply of IL-4, of which adipose tissue eosinophils are a crucial source 75, 118 . The number of adipose tissue eosinophils inversely correlates with the level of obesity in mice 118, 119 , and eosinophildeficient mice fed a high-fat diet had increased adiposity and compromised tolerance to insulin and glucose 118 . Importantly, this phenotype was reversed upon reintroduction of eosinophils 118 . Upstream of eosinophils, ILC2s are the main source of IL-5 within VAT, and the number of ILC2s correlates with the number of eosinophils (for example, mice that are devoid of ILC2s have a concomitant reduction in the number of VAT eosinophils) 75 . Therefore, an emerging paradigm suggests that the coordinated actions of ILC2s, eosinophils and M2 macrophages regulate metabolic homeostasis in VAT.
Thermoregulation. The participation of eosinophils in metabolic processes includes a role in thermoregulation 120, 121 . In response to cold or shivering, M2 macrophage-derived catecholamines induce a pro-thermogenic phenotype in adipocyte precursors, characterized by overexpression of mitochondrial brown fat uncoupling protein 1. The resulting uncoupling of mitochondrial proton gradients in beige adipocytes increases energy expenditure, which is dissipated as heat, thereby promoting thermoregulation. Within poorly innervated white adipose tissue, adipocyte beiging is driven by eosinophil-derived IL-4. IL-4 activates IL-4Rα-STAT6 signalling pathways in M2 macrophages, which promote the expression of tyrosine hydroxylase, the ratelimiting enzyme in the production of catecholamines. Thermogenic demands are thereby met by increasing the mass of beige fat within white adipose tissue 121 .
Immune homeostasis Early B cell activation. In T cell-dependent immune responses, B cells acquire cognate antigens through surface-expressed B cell receptors (BCRs). Antigen acquired through BCRs is processed, and antigenic peptides are presented on surface-expressed MHC class II molecules. Crosslinking of MHC class II molecules on IL-4-primed B cells leads to B cell activation 122, 123 , which is characterized by an intracellular Ca 2+ flux, upregulation of IgM production and proliferation [124] [125] [126] . Vaccine adjuvants such as alum facilitate early B cell activation at least in part by eliciting the infiltration of IL-4-expressing eosinophils into bone marrow and spleen compartments 122, 127 . Adjuvant-elicited eosinophils express IL-4, IL-6, IL-10, TNF and the plasma cell survival factor APRIL 128 and are required for early alum-induced activation of B cells and the production of antigen-specific IgM 127 . In both mice and humans, eosinophils also support increased numbers of peripheral B cells 129 ; and in mice, eosinophils promote B cell survival, proliferation and immunoglobulin secretion by a contact-independent mechanism 129 .
Maintenance of bone marrow plasma cells. Downstream of acute B cell activation, long-term humoral immunity is provided by antibody-secreting plasma cells. Plasma cells develop primarily within germinal centres of lymphoid tissues before migrating into specialized bone marrow niches where the cytokine microenvironment (including APRIL, IL-4, IL-6, IL-10 and TNF) is crucial in promoting their maturation and long-term survival. Eosinophils colocalize with plasma cells within bone marrow compartments and are a predominant source of IL-6 and APRIL 29, 130 . Ex vivo co-culture of eosinophils with plasma cells promoted plasma cell survival 130 , and eosinophil-deficient mice had decreased numbers of bone marrow plasma cells compared with wild-type mice despite the normal development, differentiation and antibody-affinity maturation of B cells. These results directly implicate eosinophils and their products in maintaining the long-term survival of bone marrow plasma cells 128 .
Regulation of mucosal IgA. Unlike the dominant role of IgG in systemic humoral immune responses, humoral immunity at mucosal surfaces is mediated mainly by IgA antibodies. Most secretory IgA is produced by plasma cells that reside within the intestinal lamina propria. Mucosal IgA has crucial roles in the front-line defence of mucosal surfaces interfacing with the environment and exerts a strong influence on the composition of the microbiota 131 . Driven by the constitutive expression of eotaxin 1, eosinophils home to all regions of the gastrointestinal tract (except the oesophagus), and intestinal eosinophils, similarly to bone marrow eosinophils, express plasma cell survival factors including APRIL, IL-6 and TGFβ1. Mice in which eosinophils were either temporarily depleted (using Siglec-F-specific anti bodies) or genetically ablated (for example, in ΔdblGATA or PHIL mice) had decreased numbers of IgA-secreting lamina propria B cells, and IgA levels were restored upon reintroduction of eosinophils through adoptive transfer of lamina propria cells from wild-type mice. These results implicate eosinophils in the maintenance of intestinal mucosal IgA levels 110, 111 . As might be expected, the loss of IgA-secreting plasma cells in eosinophil-deficient mice was accompanied by alterations in the mucous layer and the microbial composition of the intestinal tract (reviewed in REF. 128 ).
Central T cell tolerance. In the steady state, local expression of eotaxin 1 attracts eosinophils into the neonatal mouse thymus, where they localize primarily within the cortico-medullary region 13 . Eosinophils are similarly observed within medullary regions in thymi of young children 132 . A main function of the thymus is to negatively select (in other words, delete) T cells that are reactive to self-antigens, and the cortico-medullary region where eosinophils accumulate is an active site of self-reactive T cell deletion. A mouse model of MHC class I-restricted thymic T cell deletion showed eosinophil infiltration in close proximity to extensive thymocyte apoptosis, which led to the hypothesis that thymic eosinophils might function in T cell negative selection 13 . Further supporting a potential immunomodulatory function for thymic eosinophils, human blood and thymic eosinophils express indoleamine 2,3-dioxygenase (IDO), which catalyses the rate-limiting step in the catabolism of tryptophan to kynurenines 132, 133 . IDO-catalysed pathways thus deplete local tryptophan levels (which are necessary for cell proliferation and protein biosynthesis) and contribute kynurenines (which inhibit cell proliferation and promote the apoptosis, specifically, of T H 1 cells, but not T H 2 cells). In addition, nonspecific apoptosis of thymic T cells induced by gamma irradiation leads to the infiltration of eosinophils in the vicinity of apoptotic T cells. Deletion of eosinophils or neutrophils impaired the clearance of apoptotic debris in the thymus, which suggests that eosinophils support macrophage-mediated phagocytosis of apoptotic cells 134 . Taken together, these data suggest that eosinophils have immunomodulatory roles in defining the T cell repertoire and/or more generalized participation in innate immune responses to apoptotic cell death.
Eosinophils in other host responses
The increasing recognition of tissue eosinophils as sources of cytokines, as well as other protein, oxidative and lipid mediators, is providing evolving insights into the roles of eosinophils in diverse host responses that have often not previously been linked to eosinophil function. Eosinophils contribute to adaptive immunity through the production of DC and effector T H cell chemo attractants such as EDN, CCL17, CCL22, CXC-chemokine ligand 9 (CXCL9) and CXCL10 (REFS 27, 71, 72, 135, 136) ; and by functioning as antigen-presenting cells 137, 138 . Eosinophils can be involved in tumour rejection by normalizing tumour vessels and enhancing the infiltration of CD8 + T cells, owing to eosinophil secretion of IFNγ, TNF, CCL5, CXCL9 and CXCL10 (REF. 139 ). For host defence responses to non-classical microbial targets, eosinophil-derived IL-25 helps to mediate protection from protozoan parasite-elicited amoebic colitis 140 , and eosinophils, as sources of IL-23 and IL-17, are immunomodulatory in fungal aspergillosis 141 . In response to systemic IL-33 administration, ILC2-derived IL-5 and the associated eosinophil recruitment have both been shown to promote increased pulmonary artery hypertrophy, which is a previously unrecognized role for eosino phils 142 . Moreover, eosinophils have roles in regulating peri vascular adipose tissue and vascular functionality through the production of adiponectin and nitric . This last finding is a reminder that eosinophils are sources not only of conventional cytokines but also of a diversity of other mediators that contribute to their roles in homeostasis and immunity.
Conclusions and perspectives
Our evolving understanding of the varied functional capacities of eosinophils as cells of the innate immune system in steady-state tissues provides insights into how we can further explore the roles of eosinophils in tissues and elsewhere and better define the cellular and molecular mechanisms that control their varied responses. Early studies of the roles of eosinophils in host responses, immunity and allergic inflammation focused on the potential effects of eosinophil degranulation, with release of the cardinal cationic proteins that are uniquely packaged within eosinophil granules. However, eosinophils are also both sources of and responders to diverse cytokines, as well as many other mediators, including lipids 144 . As discussed above, recent insights into the roles of tissue-dwelling eosinophils in the steady state are mainly based on eosinophil-derived cytokines. There remain many other basic mechanisms that could underlie the functioning of mouse and human eosinophils and remain to be delineated
In recognition of the common lineages of eosinophils, basophils and mast cells and their functions within tissue sites as innate granule-containing leukocytes, the mechanisms that have been identified in eosinophils for the secretion of granule-derived proteins, including cytokines, may also be relevant to these other cell types. Moreover, for each of these cell types localized within tissues, it remains to be determined what local stimuli function to enable their secretion of protein, oxidative and lipid mediators. It is plausible that a large number of stimuli, including locally released mediators from other cells and cell-cell and cell-matrix interactions, may function together to elicit specific regulated responses, such as the differential secretion of preformed cytokines from within eosinophils. Although there is considerable redundancy within immune responses, eosinophils in tissue sites are being recognized for their distinct roles as sources of diverse cytokines and other mediators.
